
Olema Pharmaceuticals, Inc.
NASDAQ:OLMA
Overview | Financials
Company Name | Olema Pharmaceuticals, Inc. |
Symbol | OLMA |
Currency | USD |
Price | 4.42 |
Market Cap | 302,032,302 |
Dividend Yield | 0% |
52-week-range | 2.86 - 16.62 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Sean P. Bohen M.D., Ph.D. |
Website | https://www.olema.com |
An error occurred while fetching data.
About Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD